{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:41:57Z","timestamp":1791747717125,"version":"4.3.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.cca.2006.04.018","type":"journal-article","created":{"date-parts":[[2006,6,11]],"date-time":"2006-06-11T13:31:49Z","timestamp":1150032709000},"page":"14-23","source":"Crossref","is-referenced-by-count":41,"title":["Serologic and molecular detection of human Parvovirus B19 infection"],"prefix":"10.1016","volume":"372","author":[{"given":"Dimitri","family":"Peterlana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Puccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Corrocher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Lunardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2006.04.018_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0140-6736(75)91074-0","article-title":"Parvovirus-like particles in human sera","volume":"1","author":"Cossart","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.vetmic.2003.10.004","article-title":"Human circoviruses","volume":"98","author":"Biagini","year":"2004","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib3","series-title":"Virus taxonomy: the classification and nomenclature of viruses. The seventh report of the international committee on taxonomy of viruses","author":"ICTV","year":"2000"},{"key":"10.1016\/j.cca.2006.04.018_bib4","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human Parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.cca.2006.04.018_bib5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1128\/JVI.58.3.921-936.1986","article-title":"Nucleotide sequence and genome organization of human Parvovirus B19 isolated from the serum of a child during aplastic crisis","volume":"58","author":"Shade","year":"1986","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/JVI.61.8.2395-2406.1987","article-title":"Novel transcription map for the B19 (human) pathogenic parvovirus","volume":"61","author":"Ozawa","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib7","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/JVI.62.8.2884-2889.1988","article-title":"The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells","volume":"62","author":"Ozawa","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01314155","article-title":"Comparison of 17 isolates of the human Parvovirus B19 by restriction enzyme analysis","volume":"90","author":"Morinet","year":"1986","journal-title":"Arch Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib9","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jmv.1890390413","article-title":"Partial nucleotide sequencing and characterization of human Parvovirus B19 genome DNA from damaged human fetuses and from patients with leukaemia","volume":"39","author":"Umene","year":"1993","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib10","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1099\/0022-1317-77-11-2767","article-title":"Genetic diversity of human Parvovirus B19: sequence analysis of the VP1\/VP2 gene from multiple isolates","volume":"77","author":"Erdman","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib11","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1099\/0022-1317-77-8-1781","article-title":"Sequence variability among different parvovirus isolates","volume":"77","author":"Hemauer","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib12","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jmv.2137","article-title":"Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19","volume":"66","author":"Heegaard","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib13","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-5793(99)00518-9","article-title":"Genetic heterogeneity of the immunogenic viral capsid protein region of human Parvovirus B19 isolates from an outbreak in a pediatric ward","volume":"450","author":"Takahashi","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.cca.2006.04.018_bib14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1016\/S0140-6736(05)60330-3","article-title":"Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia","volume":"352","author":"Nguyen","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1128\/JCM.37.8.2483-2487.1999","article-title":"Novel human erythrovirus associated with transient aplastic anemia","volume":"37","author":"Nguyen","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib16","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/viro.2002.1585","article-title":"Identification and characterization of a second novel human erythrovirus variant, A6","volume":"301","author":"Nguyen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.cca.2006.04.018_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1006\/viro.2002.1673","article-title":"A new parvovirus genotype persistent in human skin","volume":"302","author":"Hokynar","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.cca.2006.04.018_bib18","doi-asserted-by":"crossref","first-page":"9124","DOI":"10.1128\/JVI.76.18.9124-9134.2002","article-title":"Genetic diversity within human erythroviruses: identification of three genotypes","volume":"76","author":"Servant","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(03)00120-3","article-title":"B19 virus genome diversity: epidemiological and clinical correlation","volume":"28","author":"Gallinella","year":"2003","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib20","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1128\/JVI.61.8.2627-2630.1987","article-title":"Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures","volume":"61","author":"Ozawa","year":"1987","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib21","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1128\/JVI.68.11.7159-7168.1994","article-title":"The transcriptional regulator YY1 binds to the 5\u2032-terminal region of B19 parvovirus and regulates P6 promoter activity","volume":"68","author":"Momoeda","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib22","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.64.10.4654-4660.1990","article-title":"Mutation of lysine 405 to serine in the parvovirus H-1 NS1 abolishes its functions for viral DNA replication, late promoter trans activation, and cytotoxicity","volume":"64","author":"Li","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib23","doi-asserted-by":"crossref","first-page":"8443","DOI":"10.1128\/JVI.68.12.8443-8446.1994","article-title":"A putative nucleoside triphosphate-binding domain in the nonstructural protein of B19 parvovirus is required for cytotoxicity","volume":"68","author":"Momoeda","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib24","doi-asserted-by":"crossref","first-page":"8762","DOI":"10.1128\/JVI.73.10.8762-8770.1999","article-title":"Possible interactions between the NS-1 protein and tumor necrosis factor alpha pathways in erythroid cell apoptosis induced by human Parvovirus B19","volume":"73","author":"Sol","year":"1999","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib25","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1128\/JVI.72.4.3018-3028.1998","article-title":"Human Parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells","volume":"72","author":"Moffatt","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib26","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1128\/JVI.77.5.2915-2921.2003","article-title":"Human Parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase","volume":"77","author":"Morita","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF01586181","article-title":"Parvovirus B19 infection","volume":"15","author":"Kerr","year":"1996","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.cca.2006.04.018_bib29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/infdis\/172.5.1198","article-title":"Multiple glycosphingolipids determine the tissue tropism of Parvovirus B19","volume":"172","author":"Cooling","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib30","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1128\/JVI.75.9.4110-4116.2001","article-title":"Recombinant human Parvovirus B19 vectors: erythrocyte P antigen is necessary but not sufficient for successful transduction of human hematopoietic cells","volume":"75","author":"Weigel-Kelley","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib31","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1182\/blood-2003-05-1522","article-title":"Alpha5beta1 integrin as a cellular coreceptor for human Parvovirus B19: requirement of functional activation of beta1 integrin for viral entry","volume":"102","author":"Weigel-Kelley","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.cca.2006.04.018_bib32","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","article-title":"Human parvovirus arthropathy","volume":"1","author":"White","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(85)91146-8","article-title":"Human parvovirus-associated arthritis: a clinical and laboratory description","volume":"1","author":"Reid","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib34","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/art.1780330901","article-title":"Rheumatologic manifestations of human Parvovirus B19 infection in adults. Initial two-year clinical experience","volume":"33","author":"Naides","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.cca.2006.04.018_bib35","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","article-title":"Pathogenesis of human Parvovirus B19 in rheumatic disease","volume":"59","author":"Kerr","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1093\/infdis\/171.5.1360","article-title":"The incidence of human Parvovirus B19 infection during pregnancy and its impact on perinatal outcome","volume":"171","author":"Gratacos","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0163-4453(99)90026-9","article-title":"Serologic study of human Parvovirus B19 infection in pregnancy in Japan","volume":"38","author":"Yaegashi","year":"1999","journal-title":"J Infect"},{"key":"10.1016\/j.cca.2006.04.018_bib38","first-page":"733","article-title":"Human parvovirus infection in pregnancy","volume":"72","author":"Rodis","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cca.2006.04.018_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003081-199903000-00016","article-title":"Parvovirus infection","volume":"42","author":"Rodis","year":"1999","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.cca.2006.04.018_bib40","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1016\/S0140-6736(01)06807-6","article-title":"Heamatological response to Parvovirus B19 infection in homozygous sickle-cell disease","volume":"358","author":"Serjeant","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib41","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2141.1988.tb02442.x","article-title":"Human Parvovirus B19-induced transient pancytopenia in a child with hereditary spherocytosis","volume":"70","author":"Hanada","year":"1988","journal-title":"Br J Haematol"},{"key":"10.1016\/j.cca.2006.04.018_bib42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198707303170506","article-title":"Chronic bone marrow failure due to persistent B19 parvovirus infection","volume":"317","author":"Kurtzman","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2006.04.018_bib43","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure cell aplasia of 10\u00a0years' duration due to persistent Parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cca.2006.04.018_bib44","doi-asserted-by":"crossref","first-page":"926","DOI":"10.7326\/0003-4819-113-12-926","article-title":"Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS","volume":"15, 113","author":"Frickhofen","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2006.04.018_bib45","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00043426-198921000-00024","article-title":"Parvovirus B19 infection in patients receiving cancer chemotherapy: the expanding spectrum of disease","volume":"11","author":"Graeve","year":"1989","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/j.cca.2006.04.018_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ajh.2830440314","article-title":"Human Parvovirus B19 infection in bone marrow transplantation patients","volume":"44","author":"Azzi","year":"1993","journal-title":"Am J Hematol"},{"key":"10.1016\/j.cca.2006.04.018_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/BF02560509","article-title":"Human Parvovirus B19-associated disease in bone marrow transplantation","volume":"27","author":"Schleuning","year":"1999","journal-title":"Infection"},{"key":"10.1016\/j.cca.2006.04.018_bib48","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI114274","article-title":"Immune response to B19 parvovirus and an antibody defect in persistent viral infection","volume":"84","author":"Kurtzman","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2006.04.018_bib49","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","article-title":"Chronic Parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties","volume":"28","author":"Lunardi","year":"1998","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.cca.2006.04.018_bib50","first-page":"1907","article-title":"The presence of Parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis","volume":"30","author":"Peterlana","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2006.04.018_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.0303-6987.2003.0143.x","article-title":"Parvoviral infection of endothelial cells and stromal fibroblasts: a possible pathogenetic role in scleroderma","volume":"31","author":"Magro","year":"2004","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.cca.2006.04.018_bib52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0007-0963.2004.05930.x","article-title":"Increased prevalence of human Parvovirus B19 DNA in systemic sclerosis skin","volume":"150","author":"Ohtsuka","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.cca.2006.04.018_bib53","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/80533","article-title":"Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells","volume":"6","author":"Lunardi","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.cca.2006.04.018_bib54","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0140-6736(02)11028-2","article-title":"Autoantibodies to inner ear and endothelial antigens in Cogan syndrome","volume":"360","author":"Lunardi","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib55","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1093\/infdis\/162.5.1214","article-title":"Immunoglobulin in the prophylaxis of Parvovirus B19 infection","volume":"162","author":"Schwarz","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib56","doi-asserted-by":"crossref","first-page":"9903","DOI":"10.1128\/JVI.74.21.9903-9910.2000","article-title":"Impaired gamma interferon responses against Parvovirus B10 by recently infected children","volume":"74","author":"Corcoran","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<179::AID-JMV16>3.0.CO;2-T","article-title":"Undenaturated Parvovirus B19 antigens are essential for the accurate detection of Parvovirus B19 IgG","volume":"57","author":"Kerr","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib58","doi-asserted-by":"crossref","first-page":"7327","DOI":"10.1128\/JVI.70.10.7327-7330.1996","article-title":"Lymphoproliferative responses after infection with human Parvovirus B19","volume":"70","author":"von Poblotzki","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib59","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1086\/318819","article-title":"T helper cell-mediated in vitro responses of recently and remotely infected subjects to a candidate recombinant vaccine for human Parvovirus B19","volume":"183","author":"Franssila","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JVI.75.1.540-543.2001","article-title":"Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human Parvovirus B19","volume":"75","author":"Tolfvenstam","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib61","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1099\/0022-1317-50-7-627","article-title":"Lymphocyte recognition of human Parvovirus B19 non structural (NS1) protein: association with occurrence of acute and chronic arthropaty?","volume":"50","author":"Mitchell","year":"2001","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib62","doi-asserted-by":"crossref","first-page":"e343","DOI":"10.1371\/journal.pmed.0020343","article-title":"Prolonged activation of virus-specific CD8(+)T cells after acute B19 infection","volume":"2","author":"Isa","year":"2005","journal-title":"PLoS Med"},{"key":"10.1016\/j.cca.2006.04.018_bib63","doi-asserted-by":"crossref","first-page":"261","DOI":"10.4065\/70.3.261","article-title":"Systemic monocyte and T cell activation in a patients with human Parvovirus B19 infection","volume":"70","author":"Wagner","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cca.2006.04.018_bib64","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1099\/0022-1317-82-12-3011","article-title":"Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent Parvovirus B19 infection and are associated with prolonged and chronic fatigue","volume":"82","author":"Kerr","year":"2001","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib65","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jcp.56.10.725","article-title":"Cytokine gene polymorphisms associated with symptomatic Parvovirus B19 infection","volume":"56","author":"Kerr","year":"2003","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cca.2006.04.018_bib66","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/S0140-6736(95)92950-9","article-title":"Screening of blood donors for human Parvovirus B19","volume":"346","author":"Sato","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib67","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.0042-9007.2001.00124.x","article-title":"Prevalence of human Parvovirus B19 in blood donors as determined by a haemagglutination assay and verified by the polymerase chain reaction","volume":"82","author":"Hitzler","year":"2002","journal-title":"Vox Sanguis"},{"key":"10.1016\/j.cca.2006.04.018_bib68","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1128\/JCM.38.4.1472-1475.2000","article-title":"Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human Parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women","volume":"38","author":"Jordan","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib69","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0166-0934(92)90098-X","article-title":"Recombinant Parvovirus B19 capsids as a new substrate for detection of B19-specific IgG and IgM antibodies by an enzyme-linked immunosorbent assay","volume":"39","author":"Salimans","year":"1992","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib70","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/jmv.1019","article-title":"Differential IgM response to conformational and linear epitopes of Parvovirus B19 VP1 and VP2 structural proteins","volume":"64","author":"Manaresi","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib71","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1386-6532(03)00088-X","article-title":"Detection of Parvovirus B19 IgG: choice of antigens and serological tests","volume":"29","author":"Manaresi","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib72","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0022172400070169","article-title":"The development and use of an antibody capture radioimmunoassay for specific IgM to a human parvovirus like agent","volume":"88","author":"Anderson","year":"1982","journal-title":"J Hyg Camb"},{"key":"10.1016\/j.cca.2006.04.018_bib73","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1128\/JCM.24.4.522-526.1986","article-title":"Detection of antibodies and antigens of human Parvovirus B19 by enzyme-linked immunosorbent assay","volume":"24","author":"Anderson","year":"1986","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib74","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1017\/S0022172400060095","article-title":"Diagnostic assays with monoclonal antibodies for the human serum parvovirus-like virus (SPLV)","volume":"91","author":"Cohen","year":"1983","journal-title":"J Hyg Camb"},{"key":"10.1016\/j.cca.2006.04.018_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-0934(97)00048-7","article-title":"Detection of Parvovirus B19-specific IgM by antibody capture radioimmunoassay","volume":"66","author":"Cohen","year":"1997","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib76","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0166-0934(88)90149-8","article-title":"Human Parvovirus B19: ELISA and immunoblot assay","volume":"20","author":"Schwarz","year":"1988","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib77","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1073\/pnas.88.11.4646","article-title":"Self assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions","volume":"88","author":"Kajigaya","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2006.04.018_bib78","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0168-1702(90)90028-A","article-title":"Antigenic Parvovirus B19 coat proteins VP1 and VP2 produced in a large quantities in a baculovirus expression system","volume":"15","author":"Brown","year":"1990","journal-title":"Virus Res"},{"key":"10.1016\/j.cca.2006.04.018_bib79","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1099\/0022-1317-70-11-3091","article-title":"Expression of the human Parvovirus B19 protein fused to protein A in Escherichia coli: recognition by IgM and IgG antibodies in human sera","volume":"70","author":"Morinet","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0166-0934(90)90007-3","article-title":"An immunofluorescence assay for the detection of Parvovirus B19 IgG and IgM antibodies on recombinant antigen","volume":"29","author":"Brown","year":"1990","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib81","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jcp.46.9.840","article-title":"Use of recombinant human Parvovirus B19 antigens in serological assays","volume":"49","author":"Cubie","year":"1993","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.cca.2006.04.018_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0166-0934(95)00046-W","article-title":"A synthetic Parvovirus B19 capsid protein can replace viral antigen in antibody-capture enzyme immunoassay","volume":"55","author":"Kock","year":"1995","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib83","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1128\/CDLI.3.2.236-238.1996","article-title":"Antibody response to human Parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins","volume":"3","author":"Palmer","year":"1996","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.cca.2006.04.018_bib84","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1128\/JCM.42.7.3191-3195.2004","article-title":"Comparison of three commercially available serological assays used to detect human Parvovirus B19-specific immunoglobulin M (IgM) and IgG antibodies in sera of pregnant women","volume":"42","author":"Butchko","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib85","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0166-0934(00)00227-5","article-title":"Detection of Parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis","volume":"90","author":"Doyle","year":"2000","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib86","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1093\/infdis\/172.6.1431","article-title":"Epitope type-specific IgG responses to capside proteins VP1 and VP2 of human Parvovirus B19","volume":"172","author":"S\u00f6derlund","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1002\/(SICI)1096-9071(199902)57:2<174::AID-JMV15>3.0.CO;2-0","article-title":"IgG immune response to Parvovirus B19 VP1 and VP2 linear epitopes by immunoblot assay","volume":"57","author":"Manaresi","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.biologicals.2004.09.004","article-title":"Report of a collaborative study to calibrate the Second International Standard for Parvovirus B19 antibody","volume":"32","author":"Ferguson","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.cca.2006.04.018_bib89","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/infdis\/172.5.1356","article-title":"Antibodies to nonstructural protein of Parvovirus B19 in persistently infected patients: implications for pathogenesis","volume":"172","author":"von Poblotzki","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib90","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/rheumatology\/39.8.903","article-title":"Antibodies to Parvovirus B19 nonstructural protein are associated with chronic but not acute arthritis following B19 infection","volume":"39","author":"Kerr","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2006.04.018_bib91","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/(SICI)1096-9071(199811)56:3<192::AID-JMV3>3.0.CO;2-2","article-title":"Development of antibodies to the nonstructural protein NS1 of Parvovirus B19 during acute symptomatic and subclinical infection in pregnancy: implication for pathogenesis doubtful","volume":"56","author":"Searle","year":"1998","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib92","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1086\/314894","article-title":"Antibodies to human Parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection","volume":"180","author":"Jones","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib93","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1099\/0022-1317-50-7-627","article-title":"Lymphocyte recognition of human Parvovirus B19 non-structural (NS1) protein: associations with occurrence of acute and chronic arthropathy?","volume":"50","author":"Mitchell","year":"2001","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib94","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1386-6532(01)00168-8","article-title":"Baculovirus expression of Parvovirus B19 (B19V) NS1: utility in confirming recent infection","volume":"22","author":"Ennis","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib95","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/jmv.10079","article-title":"Detection of Parvovirus B19 NS1 specific antibodies by ELISA and Western blotting employing recombinant NS1 protein as antigen","volume":"67","author":"Heegaard","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib96","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/jmv.1890150209","article-title":"Diagnosis of human Parvovirus infection by dot-blot hybridization using cloned viral DNA","volume":"15","author":"Anderson","year":"1985","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib97","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0166-0934(89)90085-2","article-title":"Rapid detection of human Parvovirus B19 DNA by dot-blot hybridization and polymerase chain reaction","volume":"23","author":"Salimans","year":"1989","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib98","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1128\/JCM.31.3.540-546.1993","article-title":"Characterization of a nested polymerase chain reaction assay for detection of Parvovirus B19","volume":"31","author":"Patou","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib99","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/BF02009384","article-title":"Persistent human Parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patient","volume":"12","author":"Cassinotti","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib100","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(96)09110-6","article-title":"Persistence of Parvovirus B19 DNA in synovial membranes of young patients with or without chronic arthropathy","volume":"349","author":"Soderlund","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib101","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(95)90850-1","article-title":"Persistent Parvovirus B19 infection","volume":"345","author":"Kerr","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2006.04.018_bib102","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.54.7.535","article-title":"Parvovirus B19 and chronic arthritis: causal or casual association?","volume":"54","author":"Woolf","year":"1995","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s100960000384","article-title":"Quantitative evidence for persistence of human Parvovirus B19 DNA in a immunocompetent individual","volume":"19","author":"Cassinotti","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.cca.2006.04.018_bib104","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mcpr.1996.0095","article-title":"Quantitation of Parvovirus B19 DNA sequences by competitive PCR: differential hybridization of the amplicons and immunoenzymatic detection on microplate","volume":"11","author":"Gallinella","year":"1997","journal-title":"Mol Cell Probes"},{"key":"10.1016\/j.cca.2006.04.018_bib105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/(SICI)1096-9071(199910)59:2<239::AID-JMV19>3.0.CO;2-Y","article-title":"Standardization of a PCR-ELISA in serum sample: diagnosis of active Parvovirus B19 infection","volume":"59","author":"Zerbini","year":"1999","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib106","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1386-6532(00)00149-9","article-title":"Validation and standardisation of nucleic acid amplification technology (NAT) assay for the detection of viral contamination of blood and blood products","volume":"20","author":"Saldanha","year":"2001","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib107","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1423-0410.2002.00132.x","article-title":"Establishment of the first World Health Organization International Standard for human Parvovirus B19 DNA nucleic acid amplification techniques","volume":"82","author":"Saldanha","year":"2002","journal-title":"Vox Sanguis"},{"key":"10.1016\/j.cca.2006.04.018_bib108","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1128\/JCM.40.6.1958-1962.2002","article-title":"High-sensitivity PCR detection of Parvovirus B19 in plasma","volume":"40","author":"Daly","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib109","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1423-0410.1997.7340207.x","article-title":"Collaborative study to assess the suitability of a proposed working reagent for human Parvovirus B19 DNA detection in plasma pools by gene amplification techniques","volume":"73","author":"Saldahna","year":"1997","journal-title":"Vox Sang"},{"key":"10.1016\/j.cca.2006.04.018_bib110","first-page":"183","article-title":"A quantitative, internally controlled real-time PCR assay for the detection of Parvovirus B19 DNA","volume":"92","author":"Aberham","year":"2001","journal-title":"J Med Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib111","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/jmv.2218","article-title":"Diagnosis and quantitative evaluation of Parvovirus B19 infections by real-time PCR in the clinical laboratory","volume":"67","author":"Manaresi","year":"2002","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib112","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1128\/JCM.42.7.3326-3328.2004","article-title":"Evaluation of a real-time PCR assay using the LightCycler System for detection of Parvovirus B19 DNA","volume":"42","author":"Buller","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib113","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jcv.2003.10.005","article-title":"Evaluation of the Roche LightCycler Parvovirus B19 quantification kit for the diagnosis of Parvovirus B19 infections","volume":"31","author":"Braham","year":"2004","journal-title":"J Clin Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib114","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jviromet.2004.05.011","article-title":"Evaluation of different assays for the detection of Parvovirus B19 DNA in human plasma","volume":"121","author":"Baylis","year":"2004","journal-title":"J Virol Methods"},{"key":"10.1016\/j.cca.2006.04.018_bib115","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1128\/JCM.42.5.2013-2019.2004","article-title":"Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests","volume":"42","author":"Hokynar","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.cca.2006.04.018_bib116","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/jmv.20251","article-title":"Recurrent high level Parvovirus B19\/Genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3","volume":"75","author":"Liefeldt","year":"2005","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib117","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1002\/jmv.2042","article-title":"Novel PCR assay for differential detection and screening of Erythrovirus B19 and Erythrovirus V9","volume":"65","author":"Heegaard","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib118","doi-asserted-by":"crossref","first-page":"12169","DOI":"10.1128\/JVI.78.22.12169-12178.2004","article-title":"Identification and characterization of persistent human erythrovirus infection in blood donor samples","volume":"78","author":"Candotti","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib119","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1128\/JVI.79.8.5238-5239.2005","article-title":"Evidence of serological cross-reactivity between genotype 1 and genotype 3 erythrovirus infections","volume":"79","author":"Corcoran","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib120","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jmv.20049","article-title":"LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates","volume":"73","author":"Schalasta","year":"2004","journal-title":"J Med Virol"},{"key":"10.1016\/j.cca.2006.04.018_bib121","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jcv.2005.04.005","article-title":"Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic samples","volume":"34","author":"Beersma","year":"2005","journal-title":"J Clin Virol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106002452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898106002452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,15]],"date-time":"2020-04-15T11:40:07Z","timestamp":1586950807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898106002452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":121,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0009898106002452"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2006.04.018","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}